| scholarly article | Q13442814 |
| P2093 | author name string | J C Lee | |
| K S Lee | |||
| J A Lee | |||
| Y S Park | |||
| Y K Kang | |||
| K H Lee | |||
| T Y Kim | |||
| H J Yoon | |||
| H C Kim | |||
| W K Kim | |||
| D S Heo | |||
| N K Kim | |||
| Y H Park | |||
| D B Shin | |||
| S Y Kim | |||
| Y J Bang | |||
| H Y Lim | |||
| K S Cho | |||
| E K Cho | |||
| B Y Ryoo | |||
| P2860 | cites work | Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 |
| Advances in anti-emetic therapy | Q40080106 | ||
| Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis | Q40500765 | ||
| Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group | Q49177743 | ||
| 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study | Q57278985 | ||
| P433 | issue | 3 | |
| P921 | main subject | granisetron | Q596708 |
| P304 | page(s) | 220-229 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Journal of International Medical Research | Q15758331 |
| P1476 | title | Ramosetron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisetron | |
| P478 | volume | 30 |
| Q37245902 | A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients. |
| Q80379033 | A Randomised Crossover Study Comparing Ramosetron plus Dexamethasone with Ramosetron Alone in the Prevention of Cisplatin-Induced Emesis |
| Q36068646 | A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting |
| Q35964110 | Acute emesis: moderately emetogenic chemotherapy |
| Q38928062 | Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis |
| Q41499105 | Effective Dose of Ramosetron for Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Patients |
| Q36276557 | Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting |
| Q36146524 | Influence of dosing times on cisplatin-induced peripheral neuropathy in rats |
| Q37671349 | Intravenous palonosetron compared with a combination of ramosetron and dexamethasone in preventing post operative nausea and vomiting in patients undergoing gynaecological surgeries under spinal anaesthesia, a randomised study |
| Q35196773 | Is it necessary to use prophylactics for preventing PONV? |
| Q33879790 | Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer |
| Q37631374 | PONV in Ambulatory surgery: A comparison between Ramosetron and Ondansetron: a prospective, double-blinded, and randomized controlled study |
| Q37697502 | Postoperative nausea and vomiting after total thyroidectomy: sevoflurane combined with prophylactic ramosetron vs. propofol-based total intravenous anesthesia |
| Q48594125 | RETRACTED: Prevention of nausea and vomiting with ramosetron after total hip replacement |
| Q43285990 | Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy |
| Q45775647 | Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind study |
| Q24202033 | Serotonin receptor antagonists for highly emetogenic chemotherapy in adults |
| Q24240511 | Serotonin receptor antagonists for highly emetogenic chemotherapy in adults |
| Q35196810 | The preventative effect of ramosetron on postoperative nausea and vomiting after total thyroidectomy |
| Q64097242 | The role of ramosetron in the prevention of post-spinal shivering in obstetric patients. A prospective randomized double blind study |
Search more.